Manipal Health Enterprises has announced plans to raise ₹8,000 crore (about $852 million) through a fresh share issuance as part of its initial public offering (IPO), according to its filing on Tuesday, signalling confidence in the growing demand for specialised medical services in India.
The Bengaluru-based hospital operator’s existing shareholders are also looking to offload 43.2 million shares, as detailed in the draft prospectus.
Backed by Temasek, the company is positioning itself to capitalise on the rapid expansion of India’s specialised healthcare segment. Industry experts highlight that rising private and global investments from firms such as Blackstone, Novo Nordisk, and KKR are fuelling this growth.
Over recent years, Manipal Health has been one of the most active consolidators in the sector, most notably acquiring Sahyadri Hospitals for $700 million.
However, the IPO comes at a challenging time, with Indian equity markets experiencing volatility due to global risk aversion, tightening liquidity, and sustained foreign investor outflows.
The company intends to utilise the proceeds from the fresh issue to reduce debt and fund its acquisition of Sahyadri Hospitals.